Search results

Ocugen OCGN is advancing three one-time gene therapy programs for retinal diseases, each aimed at conditions with large unmet needs and limited effective options.

The company’s late-stage calendar

Ocugen OCGN is advancing a late-stage ophthalmology pipeline built around one-time gene therapies for retinal diseases with large unmet needs. Multiple clinical readouts and regulatory milestones

Investors might want to bet on State Street Corporation (STT), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price

In the latest trading session, Deere (DE) closed at $579.99, marking a -1.24% move from the previous day. This change lagged the S&P 500's daily gain of 1.05%. At the same time, the Dow added 0.69%

In the latest trading session, Caterpillar (CAT) closed at $808.87, marking a +1.05% move from the previous day. The stock's performance was in sync with S&P 500. At the same time, the Dow added

Dynatrace (DT) closed the most recent trading day at $36.14, moving +1.18% from the previous trading session. The stock's change was more than the S&P 500's daily gain of 1.05%. At the same time

Trip.com (TCOM) closed the most recent trading day at $53.95, moving -1.28% from the previous trading session. This change lagged the S&P 500's daily gain of 1.05%. At the same time, the Dow added